Nikolaos Chaleplidis

Nikolaos Chaleplidis

Auto-generated profile, based on publicly available information

Nikolaos Chaleplidis

Department of Pathology, 251 Air Force General Hospital, Athens, Greece

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 December 2025 in Folia Medica
Verified
Journal Article
Open access
AKAreti Kalfoutzou
Areti Kalfoutzou
AMAdam Mylonakis
Adam Mylonakis
MTMargaritis Tsantopoulos
Margaritis Tsantopoulos
NCNikolaos Chaleplidis
Nikolaos Chaleplidis
CPChristos Piperis
Christos Piperis
EMEleni Mostratou
Eleni Mostratou
Light chain amyloidosis (AL) is a rare systemic disorder caused by the accumulation of immunoglobulin light chains in various organs, most notably the heart. Its clinical presentation is often nonspecific, leading to delayed diagnosis and poor prognosis. We report the case of a 71-year-old woman who presented with macroglossia and periorbital ecchymosis, symptoms that persisted for six years before diagnosis, along with dyspnea on exertion for the past year. Comprehensive evaluation revealed AL amyloidosis with significant cardiac involvement, evidenced by echocardiographic findings of concentric ventricular wall thickening and diastolic dysfunction consistent with restrictive cardiomyopathy. Laboratory workup confirmed elevated serum free light chains (FLC), and histopathology demonstrated the presence of amyloid deposits confirming the diagnosis. This case acknowledges cardiac AL amyloidosis as a rare cause of cardiac failure with preserved ejection fraction, often accompanied by systemic manifestations of the disease such as macroglossia and periorbital ecchymosis, and highlights the critical need for high clinical suspicion and early recognition of cardiac involvement in AL patients.